نتایج جستجو برای: rsv

تعداد نتایج: 4323  

2015
Guijun Wan Shoulin Jiang Wenjing Wang Guoqing Li Xiaorong Tao Weidong Pan Gregory A. Sword Fajun Chen

Virus-vector relationships can be complex and diverse as a result of long-term coevolution. Understanding these interactions is crucial for disease and vector management. Rice stripe virus (RSV) is known to be transovarially transmitted within its vector, Laodelphax striatellus, and causes serious rice stripe disease. In RSV-infected L. striatellus, we found contrasting changes in vector fecund...

Journal: :Journal of virology 2008
Ruyi Xiong Jianxiang Wu Yijun Zhou Xueping Zhou

Rice stripe virus (RSV) is the type member of the genus Tenuivirus. RSV has four single-stranded RNAs and causes severe disease in rice fields in different parts of China. To date, no reports have described how RSV spreads within host plants or the viral and/or host factor(s) required for tenuivirus movement. We investigated functions of six RSV-encoded proteins using trans-complementation expe...

Journal: :American journal of physiology. Endocrinology and metabolism 2011
Carolina Centeno-Baez Patrice Dallaire André Marette

The plant-derived polyphenol resveratrol (RSV) modulates life span and metabolism, and it is thought that these effects are largely mediated by activating the deacetylase enzyme SIRT1. However, RSV also activates the cell energy sensor AMP-activated protein kinase (AMPK). We have previously reported that AMPK activators inhibit inducible nitric oxide synthase (iNOS), a key proinflammatory media...

Journal: :Journal of virology 2006
Luis Martinez-Sobrido Negin Gitiban Ana Fernandez-Sesma Jerome Cros Sara E Mertz Nancy A Jewell Sue Hammond Emilio Flano Russell K Durbin Adolfo García-Sastre Joan E Durbin

Respiratory syncytial virus (RSV) is a major cause of severe lower respiratory tract disease in infants and the elderly, but no safe and effective RSV vaccine is yet available. For reasons that are not well understood, RSV is only weakly immunogenic, and reinfection occurs throughout life. This has complicated the search for an effective live attenuated viral vaccine, and past trials with inact...

Journal: :The Journal of clinical investigation 2014
Gregory H Bird Sandhya Boyapalle Terianne Wong Kwadwo Opoku-Nsiah Raminder Bedi W Christian Crannell Alisa F Perry Huy Nguyen Viviana Sampayo Ankita Devareddy Subhra Mohapatra Shyam S Mohapatra Loren D Walensky

Respiratory syncytial virus (RSV) infection accounts for approximately 64 million cases of respiratory disease and 200,000 deaths worldwide each year, yet no broadly effective prophylactic or treatment regimen is available. RSV deploys paired, self-associating, heptad repeat domains of its fusion protein, RSV-F, to form a fusogenic 6-helix bundle that enables the virus to penetrate the host cel...

Journal: :Antimicrobial agents and chemotherapy 2005
Asunción Mejías Susana Chávez-Bueno Ana María Ríos Mónica Fonseca Aten Brett Raynor Estrella Peromingo Perla Soni Kurt D Olsen Peter A Kiener Ana María Gómez Hasan S Jafri Octavio Ramilo

Respiratory syncytial virus (RSV) is the leading viral pathogen responsible for bronchiolitis and pneumonia in infants and young children worldwide. We have previously shown in the mouse model that treatment with an anti-RSV neutralizing monoclonal antibody (MAb) against the F glycoprotein of RSV, palivizumab, decreased lung inflammation, airway obstruction, and postmethacholine airway hyperres...

Journal: :Clinical and Developmental Immunology 2004
W. V. Kalina L. J. Gershwin

Respiratory syncytial virus (RSV), an RNA virus in the family Paramyxoviridae, causes respiratory disease in humans. A closely related bovine RSV is responsible for a remarkably similar disease syndrome in young cattle. Severe RSV disease is characterized by bronchiolitis. The impact of RSV on human health is demonstrated annually when infants are admitted to the hospital in large numbers. Near...

2017
Jennifer Claydon Amitava Sur Allison Callejas Mihoko Ladd Eddie Kwan Richard Taylor Stuart E Turvey Alfonso Solimano Pascal M Lavoie Nico Marr

BACKGROUND Monthly injections of palivizumab during the respiratory syncytial virus (RSV) season in at-risk infants reduces RSV-associated hospitalizations. However, the additive effect of naturally acquired immunity remains unclear. The objective of this study was to assess total neutralizing serum antibodies (NAb) against RSV in at-risk infants who had received an abbreviated course of palivi...

2016
Matthew R. Murawski Glennice N. Bowen Anna M. Cerny Larry J. Anderson Lia M. Haynes Ralph A. Tripp Evelyn A. Kurt-Jones Lori W. McGinnes Robert W. Finberg Evelyn A. Kurt

Respiratory syncytial virus (RSV) causes a common infection that is associated with a range of respiratory illnesses from common cold-like symptoms to serious lower respiratory tract illnesses such as pneumonia and bronchiolitis. RSV is the single most important cause of serious lower respiratory tract illness in children < 1 year of age. Host innate and acquired immune responses activated foll...

Journal: :Journal of virology 2005
Michel Liuzzi Stephen W Mason Mireille Cartier Carol Lawetz Robert S McCollum Nathalie Dansereau Gordon Bolger Nicole Lapeyre Yvon Gaudette Lisette Lagacé Marie-Josée Massariol Florence Dô Paul Whitehead Lyne Lamarre Erika Scouten Josée Bordeleau Serge Landry Jean Rancourt Gulrez Fazal Bruno Simoneau

Respiratory syncytial virus (RSV) is a major cause of respiratory illness in infants, immunocompromised patients, and the elderly. New antiviral agents would be important tools in the treatment of acute RSV disease. RSV encodes its own RNA-dependent RNA polymerase that is responsible for the synthesis of both genomic RNA and subgenomic mRNAs. The viral polymerase also cotranscriptionally caps a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید